Education
About Us
Working with TipRanks
Follow Us
Tenax Therapeutics (TENX)
NASDAQ:TENX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -7.57K | $ -113.33K | $ -108.98K | $ -114.75K |
| Operating Income | $ -19.49M | $ -8.23M | $ -11.05M | $ -32.73M | $ -9.87M |
| EBITDA | $ -17.58M | $ -7.68M | $ -10.93M | $ -32.36M | $ -9.74M |
| Net Income | $ -17.60M | $ -7.71M | $ -11.05M | $ -32.47M | $ -9.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 94.85M | $ 9.79M | $ 2.12M | $ 5.58M | $ 6.71M |
| Total Assets | $ 96.69M | $ 11.68M | $ 3.40M | $ 5.99M | $ 6.87M |
| Total Debt | $ 0.00 | $ 500.90K | $ 807.89K | $ 290.78K | $ 305.04K |
| Net Debt | $ -94.85M | $ -9.29M | $ -1.32M | $ -5.29M | $ -5.95M |
| Total Liabilities | $ 4.69M | $ 3.59M | $ 1.91M | $ 1.75M | $ 2.24M |
| Stockholders' Equity | $ 91.99M | $ 8.10M | $ 1.49M | $ 4.24M | $ 4.63M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.81M | $ -5.90M | $ -12.02M | $ -10.86M | $ -9.28M |
| Operating Cash Flow | $ -14.81M | $ -5.90M | $ -12.01M | $ -10.86M | $ -9.27M |
| Investing Cash Flow | $ 0.00 | $ 2.84K | $ -2.32K | $ 452.61K | $ 20.11K |
| Financing Cash Flow | $ 99.87M | $ 13.57M | $ 8.55M | $ 9.74M | $ 10.60M |